Turkish Journal of Medical Sciences
DOI
10.3906/sag-1709-134
Abstract
Background/aim: Soluble urokinase plasminogen activator receptor (suPAR) has been reported to have a positive correlation with the activation degree of the immune system. This study's aim is to investigate the efficiency of SuPAR serum levels in acute pancreatitis (AP) patients in determining the severity of disease. Materials and methods: This prospective research involves patients who arrived at the emergency service, were over 18 years old, had nontraumatic abdominal pain and diagnosis of AP, and agreed to join the study. Demographic characteristics, contact information, laboratory and imaging test parameters, Ranson's criteria, the Balthazar Severity Index, the Rapid Acute Physiologic Score (RAPS), and the modified Glasgow (Imrie) score of all patients were recorded. Two study groups were created as score of
Keywords
Acute pancreatitis, biomarker, abdominal pain, suPAR
First Page
1175
Last Page
1181
Recommended Citation
KÜÇÜKCERAN, KADİR; ERGİN, MEHMET; KILINÇ, İBRAHİM; KARAİBRAHİMOĞLU, ADNAN; ÇOLAK, TAMER; TUNCAR, ALPAY; DÜNDAR, ZERRİN DEFNE; KOÇAK, SEDAT; GİRİŞGİN, ABDULLAH SADIK; GÜL, MEHMET; and CANDER, BAŞAR
(2018)
"The role of soluble urokinase plasminogen activator receptor (SuPAR) as an indicator of the severity of acute pancreatitis,"
Turkish Journal of Medical Sciences: Vol. 48:
No.
6, Article 15.
https://doi.org/10.3906/sag-1709-134
Available at:
https://journals.tubitak.gov.tr/medical/vol48/iss6/15